查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年全球微阵列市场预测：按产品、类型、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383449

2030 年全球微阵列市场预测：按产品、类型、应用、最终用户和地区进行的全球分析

Microarray Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Software & Services), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球微阵列市场规模将达到 47 亿美元，预计到 2030 年将达到 90.4 亿美元，预测期内年复合成长率为 9.8%。

在基因组学和分子生物学中，微阵列是一种有效的技术，可以同时高通量研究许多基因、蛋白质和其他物质。该市场由多种类型的微阵列组成，包括 DNA、蛋白质和组织微阵列，在研究、诊断和药物开发方面提供广泛的应用。自订微阵列由多个组织和研究人员创建，以满足他们独特的研究需求。

根据英国皇家化学学会 2019 年发表的一项研究，连接到智慧型手机的便携式萤光微阵列成像系统正在用于检测乳癌基因表现。

微阵列在各种应用中的使用增加

由于微阵列被用于各种应用，微阵列市场正在扩大。随着越来越多的科学家和组织在临床诊断、蛋白质组学、基因组学和其他领域使用微阵列，对微阵列产品和服务的需求不断增加。近年来，微阵列已被应用于药物开发、蛋白质体学、临床诊断、基因组学和环境监测等更多领域。这种多样性使得市场对特定产业的变化更具弹性，并使其不断发展。药物开发在很大程度上依赖微阵列，因为它们有助于标靶识别、毒性评估和生物标记发现。

与次世代定序仪（NGS）的竞争

次世代定序技术可以获得完整的分子和基因组资料。因此，微阵列在各种应用中的市场占有率正在下降。次世代定序仪因其广泛的资讯和执行高通量测序的能力而经常被研究人员和医生使用。在考虑技术时，人们很容易认为次世代定序仪比微阵列更强大、更复杂。这种思维方式不利于在研究和其他情况下使用微阵列而支援次世代定序仪，并可能阻碍微阵列业务的扩展。

个人化医疗意识不断增强

个别患者的分子分析是个人化医疗製化药物介入的基础。微阵列对于创建每个患者特有的遗传和分子资料至关重要。患者和医疗保健专业人员对个体化医疗潜在好处的认识不断提高，导致对这些技术的需求激增。在个体化医疗领域，研究人员、医疗保健专业人员和生技公司之间的跨学科合作正变得越来越广泛。

高可维护性

缺乏合格人员可能会阻碍微阵列技术的采用。如果研究机构和临床实验室缺乏具备正确操作技术所需技能的员工，他们可能不愿意投资微阵列平台。分析微阵列资料很困难，需要生物资讯学知识。缺乏合格的专家可能会导致资料处理效率低下、研究结果延迟或误解，并减少科学产出。

COVID-19 的影响

微阵列透过研究宿主对病毒的反应、改变患者的基因表现以及创建诊断测试，为 COVID-19 研究做出了贡献。因此，对基于病毒特异性微阵列的测试的需求增加。因此，疫情导致某些地区的研究资金筹措目标发生变化，重点是疫苗开发和感染疾病研究。此外，一旦大流行的严重阶段过去，随着更多资金投入蛋白质体学和基因组学等生命科学研究，微阵列市场可能会成长。

蛋白质微阵列领域预计将在预测期内成为最大的领域

在蛋白质体学研究中，蛋白质微阵列是研究蛋白质的性质、关係和作用的有效且适应性强的工具，因此蛋白质微阵列领域预计将经历良好的成长。与检查基因表现的 DNA 微阵列相比，蛋白质微阵列能够对蛋白质和其他分子之间的结合相互作用进行高通量分析。蛋白质微阵列技术的进步正在产生日益复杂的系统，其灵敏度、特异性和通量也不断提高。

疾病诊断领域预计在预测期内年复合成长率最高

与遗传疾病、癌症、感染疾病和染色体异常相关的单核苷酸多态性（SNP）都是使用这些微阵列发现的，使得疾病诊断领域有望在预测期内出现最高的年复合成长率年增长率。这些微阵列使用组织切片和培养细胞来研究各种疾病中的蛋白质-蛋白质相互作用、基因表现模式和蛋白质定位。此外，这些诊断微阵列可以在个人化医疗时代根据患者的遗传和分子特征量身定制治疗计划，从而促进市场成长。

比最大的地区

预计亚太地区将在预测期内占据最大的市场占有率，因为对尖端医疗保健解决方案的需求不断增长以及基因组学和个人化医疗研发的加强正在推动市场扩张。亚太地区是积极从事微阵列研究和开发的学术机构、研究机构和生物技术公司的所在地。这包括为特定应用创建微阵列以及识别各种疾病的生物标记。

复合年复合成长率最高的地区：

北美是微阵列技术最大、最发达的市场之一，因此预计在预测期内年复合成长率最高。尤其美国，是微阵列生产和研究的重要中心。北美微阵列市场由许多提供微阵列平台、试剂和服务的跨国和本地公司主导。安捷伦科技、Illumina、Thermo Fisher Scientific、PerkinElmer 等是该领域的主要企业，正在推动该地区的市场成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球微阵列市场：依产品

  • 消耗品
  • 装置
  • 软体服务

第6章全球微阵列市场：依类型

  • 蛋白质微阵列
  • DNA微阵列
  • 其他微阵列

第7章全球微阵列市场：依应用分类

  • 药物研发
  • 疾病诊断
  • 研究用途
  • 农业
  • 其他用途

第8章全球微阵列市场：依最终用户分类

  • 製药和生物技术公司
  • 研究/学术机构
  • 诊断实验室
  • 其他最终用户

第9章全球微阵列市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Molecular Devices, LLC
  • Affymetrix
  • Merck & Co., Inc.
  • Arrayit Corporation
  • Microarrays;Inc.
  • NextGen Sciences
  • bioMerieux SA
  • RayBiotech Life, Inc
  • PathogenDx
  • Diasorin Group
  • Schott Minifab
  • Full Moon Biosystems.Inc
  • CapitalBio Technology Co, Ltd
Product Code: SMRC24297

According to Stratistics MRC, the Global Microarray Market is accounted for $4.70 billion in 2023 and is expected to reach $9.04 billion by 2030 growing at a CAGR of 9.8% during the forecast period. In genomics and molecular biology, microarrays are an effective technology that allow for the high-throughput, simultaneous investigation of many genes, proteins, or other substances. The market offers a broad variety of applications in research, diagnostics, and drug development and comprises many types of microarrays, including DNA, protein, and tissue microarrays. Custom microarrays are created by several organizations and researchers to meet their unique research requirements.

According to a research study published by the Royal Society of Chemistry in 2019, a portable fluorescence microarray imaging system that connects to a smartphone has been used for the detection of breast cancer gene expression.

Market Dynamics:

Driver:

Rise in the usage of microarrays in various applications

The market for microarrays has grown as a result of the growing use of microarrays in various applications. The need for microarray goods and services has increased as more scientists and organizations use them for clinical diagnostics, proteomics, genomics, and other areas. These days, microarrays are employed in many more fields, such as drug development, proteomics, clinical diagnostics, genomics, and environmental monitoring due to this diversity, the market is now more resilient to changes in certain industries and has been able to develop continuously. Drug development relies heavily on microarrays because they make target identification, toxicity assessment, and biomarker discovery easier.

Restraint:

Competition from next-generation sequencing (NGS)

Next-generation sequencing technologies can give complete molecular and genomic data; they have become more and more popular. They have so reduced microarrays' market share across a range of applications. Because of Next-generation sequencing breadth of information and high-throughput sequencing capabilities, researchers and physicians frequently use it. When considering technologies, it is frequently thought to be more potent and sophisticated than microarrays. This idea may discourage the use of microarrays in favour of next-generation sequencing in research and other settings, which might stunt the expansion of the microarray business.

Opportunity:

Growing awareness regarding personalized medicines

Molecular profiling of individual patients is the foundation of personalized medicine, which customizes medicinal interventions. In order to produce genetic and molecular data particular to each patient, microarrays are essential. The growing awareness among patients and healthcare professionals of the potential advantages of customized medicine has led to a surge in demand for these technologies. In the realm of customized medicine, interdisciplinary collaboration between researchers, healthcare practitioners, and biotechnology businesses is becoming more widespread.

Threat:

High maintenance

Microarray technology adoption may be hindered by the lack of qualified workers. If research organizations and clinical labs lack the staff with the necessary skills to properly run the technology, they can be reluctant to invest in microarray platforms. The analysis of microarray data might be challenging and call for bioinformatics knowledge. A shortage of qualified experts might lead to ineffective data processing, which would postpone research results, misunderstand them, and decrease scientific output thus hampering the market growth.

COVID-19 Impact

Through the investigation of host responses to the virus, patient gene expression alterations, and the creation of diagnostic tests, microarrays contributed to COVID-19 research. As a result, there was a rise in demand for virus-specific microarray-based tests. Thus, the pandemic caused changes in certain regions' objectives for financing research, with an emphasis on developing vaccines and researching infectious diseases. Furthermore, the market for microarrays may grow if more money is invested in life sciences research, like as proteomics and genomics, once the pandemic's acute phase has passed.

The protein microarrays segment is expected to be the largest during the forecast period

The protein microarrays segment is estimated to have a lucrative growth, as these proteomics research, protein microarrays are an effective and adaptable tool for examining the characteristics, relationships, and roles of proteins. Protein microarrays enable high-throughput analysis of the binding interactions of proteins and other molecules, much to DNA microarrays, which are used to examine gene expression. The advancement of protein microarray technology has produced increasingly sophisticated systems with improved sensitivity, specificity, and throughput.

The diseases diagnostics segment is expected to have the highest CAGR during the forecast period

The diseases diagnostics segment is anticipated to witness the highest CAGR growth during the forecast period, because the single nucleotide polymorphisms (SNPs) linked to genetic disorders, cancer, and infectious illnesses, as well as chromosomal abnormalities, are all found using these microarrays. These microarrays investigate protein-protein interactions, gene expression patterns, and protein localization in a variety of disorders using tissue slices or cultured cells. Moreover these diagnostic microarrays allow for customized treatment plans based on a patient's genetic or molecular profile in the age of personalized medicine thereby boosting the market growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising demand for cutting-edge healthcare solutions as well as enhanced genomics and personalized medicine research and development efforts are responsible for this expansion. The Asia Pacific area is home to several academic institutions, research labs, and biotechnology corporations that are actively involved in microarray research and development. This involves the creation of personalized microarrays for particular uses and the identification of biomarkers for a range of illnesses.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period; owing to one of the biggest and most developed markets for microarray technology. Particularly, the US is a significant centre for microarray creation and research. The North American microarray market is occupied by a number of multinational and local businesses that offer microarray platforms, reagents, and services. Agilent Technologies, Illumina, Thermo Fisher Scientific, PerkinElmer, and many more are some of the major companies in this sector are driving the market growth in this region.

Key players in the market

Some of the key players profiled in the Microarray Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix, Merck & Co., Inc., Arrayit Corporation, Microarrays; Inc., NextGen Sciences, bioMerieux SA, RayBiotech Life, Inc, PathogenDx, Diasorin Group, Schott Minifab, Full Moon Biosystems.Inc and CapitalBio Technology Co, Ltd

Key Developments:

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In October 2023, Thermo Fisher Scientific announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.

In September 2023, Agilent Technologies Inc recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.

Products Covered:

  • Consumables
  • Instruments
  • Software & Services

Types Covered:

  • Protein Microarrays
  • DNA Microarrays
  • Other Microarrays

Applications Covered:

  • Drug Discovery
  • Diseases Diagnostics
  • Research Applications
  • Agriculture
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Diagnostic Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microarray Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Instruments
  • 5.4 Software & Services

6 Global Microarray Market, By Type

  • 6.1 Introduction
  • 6.2 Protein Microarrays
  • 6.3 DNA Microarrays
  • 6.4 Other Microarrays

7 Global Microarray Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Discovery
  • 7.3 Diseases Diagnostics
  • 7.4 Research Applications
  • 7.5 Agriculture
  • 7.6 Other Applications

8 Global Microarray Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Research & Academic Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Other End Users

9 Global Microarray Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies, Inc.
  • 11.2 Thermo Fisher Scientific, Inc.
  • 11.3 Illumina, Inc.
  • 11.4 PerkinElmer, Inc.
  • 11.5 Bio-Rad Laboratories
  • 11.6 GE Healthcare
  • 11.7 Molecular Devices, LLC
  • 11.8 Affymetrix
  • 11.9 Merck & Co., Inc.
  • 11.10 Arrayit Corporation
  • 11.11 Microarrays; Inc.
  • 11.12 NextGen Sciences
  • 11.13 bioMerieux SA
  • 11.14 RayBiotech Life, Inc
  • 11.15 PathogenDx
  • 11.16 Diasorin Group
  • 11.17 Schott Minifab
  • 11.18 Full Moon Biosystems.Inc
  • 11.19 CapitalBio Technology Co, Ltd

List of Tables

  • Table 1 Global Microarray Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 4 Global Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 6 Global Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 8 Global Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 9 Global Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 10 Global Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 12 Global Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 13 Global Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 14 Global Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 15 Global Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 18 Global Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 19 Global Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 20 Global Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 23 North America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 24 North America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 25 North America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 26 North America Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 28 North America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 29 North America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 30 North America Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 North America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 32 North America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 33 North America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 34 North America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 35 North America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 36 North America Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 North America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 38 North America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 39 North America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 40 North America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 43 Europe Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 44 Europe Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 45 Europe Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 46 Europe Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 48 Europe Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 49 Europe Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 50 Europe Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 51 Europe Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 52 Europe Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 53 Europe Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 54 Europe Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 55 Europe Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 56 Europe Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 Europe Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 58 Europe Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 59 Europe Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 60 Europe Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 63 Asia Pacific Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 64 Asia Pacific Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 65 Asia Pacific Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 66 Asia Pacific Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 67 Asia Pacific Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 68 Asia Pacific Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 69 Asia Pacific Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 70 Asia Pacific Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 71 Asia Pacific Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 72 Asia Pacific Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 73 Asia Pacific Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 74 Asia Pacific Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 75 Asia Pacific Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 76 Asia Pacific Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 77 Asia Pacific Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 78 Asia Pacific Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 79 Asia Pacific Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 80 Asia Pacific Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 83 South America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 84 South America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 85 South America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 86 South America Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 87 South America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 88 South America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 89 South America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 90 South America Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 South America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 92 South America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 93 South America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 94 South America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 95 South America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 96 South America Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 South America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 98 South America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 99 South America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 100 South America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Microarray Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Microarray Market Outlook, By Product (2021-2030) ($MN)
  • Table 103 Middle East & Africa Microarray Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 104 Middle East & Africa Microarray Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 105 Middle East & Africa Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 106 Middle East & Africa Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 107 Middle East & Africa Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 108 Middle East & Africa Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
  • Table 109 Middle East & Africa Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
  • Table 110 Middle East & Africa Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 111 Middle East & Africa Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 112 Middle East & Africa Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
  • Table 113 Middle East & Africa Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
  • Table 114 Middle East & Africa Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 115 Middle East & Africa Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 Middle East & Africa Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 118 Middle East & Africa Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 119 Middle East & Africa Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 120 Middle East & Africa Microarray Market Outlook, By Other End Users (2021-2030) ($MN)